zenith laboratori inc said food and drug administr approv cephradin antibiot for market maker generic drug less cost version brand name drug have lost patent said cephradin has been avail velosef from squibb corp and anspor from smithklin beckman corp unit earlier this week compani said receiv fda market approv for cefadroxil anoth antibiot which said will market onc question relat patent applic resolv reuter 